Search results for "forme"

showing 10 items of 1192 documents

Hyperglycemia and oxidative stress in cultured endothelial cells – a comparison of primary endothelial cells with an immortalized endothelial cell li…

2012

Diabetes mellitus is a major risk factor for the development of cardiovascular disease and oxidative stress plays an important role in this process. Therefore, we investigated the effects of hyperglycemia on the formation of reactive oxygen species (ROS) and nitric oxide/cGMP signaling in two different endothelial cell cultures. Human umbilical vein endothelial cells (HUVEC) and EA.hy 926 cells showed increased oxidative stress and impaired NO-cGMP signaling in response to hyperglycemia. The major difference between the two different cell types was the dramatic decrease in viability in HUVEC whereas EA.hy cells showed rather increased growth under hyperglycemic conditions. Starvation led to…

medicine.medical_specialtyCell typeEndotheliumCell SurvivalEndocrinology Diabetes and MetabolismPrimary Cell CultureBiologyNitric Oxidemedicine.disease_causeUmbilical veinEndocrinologyInternal medicineHuman Umbilical Vein Endothelial CellsInternal MedicinemedicineHumansEndothelial dysfunctionCyclic GMPCells CulturedCell Line Transformedchemistry.chemical_classificationReactive oxygen speciesCell DeathDose-Response Relationship Drugmedicine.diseaseEndothelial stem cellOxidative StressGlucoseEndocrinologymedicine.anatomical_structurechemistryCell cultureHyperglycemiaEndothelium VascularReactive Oxygen SpeciesOxidative stressJournal of Diabetes and its Complications
researchProduct

Informing MS patients on treatment options: a consensus on the process of consent taking

2020

Abstract\ud In the last years, change in multiple sclerosis (MS) therapeutic scenario has highlighted the need for an improved doctor-patient communication in advance of treatment initiation in order to allow patient’s empowerment in the decision-making process.\ud Aims\ud The aims of our project were to review the strategies used by Italian MS specialists to inform patients about treatment options and to design a multicentre shared document that homogenizes the information about disease-modifying treatment (DMTs) and the procedure of taking informed consent in clinical practice.\ud Results\ud The new resource, obtained by consensus among 31 neurologists from 27 MS Centres in Italy with the…

medicine.medical_specialtyConsensusProcess (engineering)media_common.quotation_subjectDermatologyDisease modifying treatment; Informed consent; Multiple sclerosisMultiple sclerosis03 medical and health sciences0302 clinical medicineResource (project management)Informed consentDisease modifying treatmentmedicineHumans030212 general & internal medicineInformed consentEmpowermentmedia_commonPhysician-Patient Relationsbusiness.industryTreatment optionsGeneral MedicineClinical PracticePsychiatry and Mental healthItalyFamily medicineDisease modifying treatment; Informed consent; Multiple sclerosis; Consensus; Humans; Italy; Physician-Patient Relations; Informed Consent; Multiple SclerosisSettore MED/26 - NeurologiaNeurology (clinical)Decision processbusiness030217 neurology & neurosurgery
researchProduct

Phenotypic Variability and Disparities in Treatment and Outcomes of Childhood Arthritis Throughout the World: Results from the EPOCA Study

2018

Background: The characteristics and burden of childhood arthritis have never been studied on a worldwide basis. We aimed to investigate prevalence of disease categories, treatment modalities and disease status across different geographic areas. Methods: International paediatric rheumatologists were asked to enrol a consecutive sample of children with juvenile idiopathic arthritis. Each patient underwent retrospective and cross-sectional assessments, including parent-reported outcomes. Level of disease activity and damage were correlated with wealth of the country, expressed as gross domestic product per capita. Findings: Between 2011 and 2016, 9,081 patients were enrolled at 130 centres in …

medicine.medical_specialtyDisease statusbusiness.industryChildhood arthritisPublic healthDeclarationmedicine.diseaseCONSECUTIVE SAMPLEInformed consentFamily medicinemedicinebusinessBristol-MyersDisease burdenSSRN Electronic Journal
researchProduct

Phase III, Multicenter Open-Label Study to Investigate the Efficacy of Elbasvir and Grazoprevir Fixed-Dose Combination for Eight Weeks in Treatment-N…

2020

Background: Genotype 1b is the most common HCV genotype worldwide, accounting for the largest proportion of infections in Europe, Russia, Latin America and Asia. Reducing treatment duration can improve adherence, reduce drug exposure and cost. Accordingly, we evaluated the efficacy of eight weeks fixed dose combination of grazoprevir-elbasvir in treatment-naive patients, with non-severe fibrosis. Methods: HCV mono-infected and treatment naive patients with non-severe fibrosis (Fibroscan®<9·5kPa and Fibrotest®<0·59) were enrolled in a study which included 117 patients. Genotyping by sequencing identified five patients with non-1b genotype (two GT1a, one GT1h, one GT1e and one GT1l). Thus, we…

medicine.medical_specialtyElbasvirbusiness.industryFixed-dose combinationHepatitis Cmedicine.diseaseClinical investigatorGrazoprevirInformed consentInternal medicineGood clinical practicemedicinebusinessViral loadSSRN Electronic Journal
researchProduct

Ethics and the treatment as prevention strategy among transgender women living with HIV in Argentina

2020

While numerous ethical concerns have been voiced regarding HIV service scale-up strategies targeting key populations, few studies have examined these from the perspective of affected groups. This study therefore sought to understand transgender women's experiences and perspectives of targeted HIV services scale-up in the context of Argentina's Treatment as Prevention strategy. In 2016, 25 purposively selected transgender women living with HIV were interviewed by a peer research associate. Interviews were audio recorded, transcribed verbatim and analysed using participatory coding techniques. Findings suggest that procedures around informed consent, including the provision of full informatio…

medicine.medical_specialtyHealth (social science)educationArgentinaHIV InfectionsContext (language use)Transgender Persons03 medical and health sciences0302 clinical medicineInformed consentHealth careTransgendermedicineHumans030212 general & internal medicine10. No inequality030505 public healthbusiness.industryPublic Health Environmental and Occupational HealthEquity (finance)Voluntariness16. Peace & justiceTreatment as prevention3. Good healthFamily medicineFemale0305 other medical sciencebusinessPsychologyInclusion (education)TranssexualismCulture, Health &amp; Sexuality
researchProduct

How reproductive and regenerative medicine meet in a Chinese fertility clinic. Interviews with women about the donation of embryos to stem cell resea…

2010

The social interface between reproductive medicine and embryonic stem cell research has been investigated in a pilot study at a large IVF clinic in central China. Methods included observation, interviews with hospital personnel, and five in-depth qualitative interviews with women who underwent IVF and who were asked for their consent to the donation of embryos for use in medical (in fact human embryonic stem cell) research. This paper reports, and discusses from an ethical perspective, the results of an analysis of these interviews. The participants talked of extreme social pressure to become pregnant. Once they had a baby, 'spare' embryos lost practical significance due to the Chinese one-…

medicine.medical_specialtyHealth (social science)media_common.quotation_subjectAlternative medicineReproductive medicinePilot ProjectsContext (language use)FertilityFertilization in VitroMoralsArts and Humanities (miscellaneous)PregnancySurveys and QuestionnairesHumansMedicineWomenEmbryo Dispositionmedia_commonInformed Consentbusiness.industryHealth PolicyTissue DonorsSolidarityFertility clinicEmbryo ResearchIssues ethics and legal aspectsDonationFamily medicineembryonic structuresFemaleStem cellbusinessStem Cell TransplantationJournal of Medical Ethics
researchProduct

Randomised clinical trials: a source of ethical dilemmas

2001

Clinical trials give rise to ethical dilemmas, especially in the acutely ill, but we take issue with two points raised in a recent comment on a specific acute myocardial infarction (AMI) trial. The commentators judged that the trial most likely could, and therefore should, have been terminated much earlier. By analysing the problem statistically we arrive at results that go against their intuitive judgment—they also see it as mandatory to update the patient Information sheet as trial results accrue and trends begin to emerge. In our view, interpreting subtle trends and borderline p-values must rest with data monitoring boards, not patients. Moreover, patients with AMI or in other medical em…

medicine.medical_specialtyHealth (social science)medicine.medical_treatmentAt the Coalface: Medical Ethics in PracticeTreatment outcomeMyocardial InfarctionAlternative medicineHospital mortalityResearch EthicsArts and Humanities (miscellaneous)Informed consentAngioplastymedicineHumansEthics MedicalThrombolytic TherapyHospital MortalityMyocardial infarctionIntensive care medicineRandomized Controlled Trials as TopicInformed Consentbusiness.industryPatient SelectionHealth PolicyAngioplastyCoronary Care Unitsmedicine.diseasehumanitiesClinical trialIssues ethics and legal aspectsTreatment OutcomeClinical researchEthics ClinicalData Interpretation StatisticalMedical emergencybusinessJournal of Medical Ethics
researchProduct

Informed consent in high-risk renal transplant recipients.

2009

Abstract Before performing a clinical, diagnostic, and/or therapeutic action, the doctor is required to provide the patient with a bulk of information defined as informed consent. This expression was used for the first time in 1957 during a court case in California and the two words— informed and consent —are used together to underline the fact that the patient cannot give his or her true consent without first receiving correct information concerning the medical act in question. With regard to the medicolegal aspects governing organ transplants, despite the bulk of detailed work performed by health service workers involved in this surgical field with the aim of preparing adequate informed c…

medicine.medical_specialtyHuman RightsRisk Assessmentinformed consent kidney transplantationHealth servicesInformed consentmedicineHumansEthics MedicalMental CompetencyIntensive care medicineTransplantationInformed Consentbusiness.industryFormalitymedicine.diseaseComorbidityKidney NeoplasmsSurgeryTransplantationSurvival RateSettore MED/18 - Chirurgia GeneraleAction (philosophy)Renal transplantQuality of LifeKidney Failure ChronicSurgeryTransplant surgeonbusinessTransplantation proceedings
researchProduct

&lt;i&gt;PCSK9&lt;/i&gt; rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD

2020

Background and Aims: The proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a key role in cholesterol homeostasis, and its inhibition represents an effective therapy to lower LDL-C levels. In this study, we examined the impact of PCSK9 rs11591147 loss-of-function (LOF) variant on liver damage in a multicenter collection of patients at risk of nonalcoholic steatohepatitis (NASH), in clinical samples and experimental models. Methods: We considered 1,874 consecutive individuals at risk of NASH as determined by histology. The SNP rs11591147, encoding for the p.R46L variant of PCSK9, was genotyped by TaqMan assays. We also evaluated 1) PCSK9 mRNA hepatic expression in human liver, and 2…

medicine.medical_specialtyHuman liverbusiness.industryPCSK9Helsinki declarationFat accumulationInformed consentInternal medicineMedicinemedia_common.cataloged_instanceLiver damageEuropean unionbusinessPharmacogeneticsmedia_commonSSRN Electronic Journal
researchProduct

Conspiracy of silence and emotional distress in patients diagnosed with glioblastoma multiforme

2012

Objetivo: En el ámbito de enfermedades muy graves y de mal pronóstico, continúa existiendo un importante porcentaje de familiares que, por motivos beneficentes y de protección, deciden ocultar la verdad a los enfermos que desean conocer lo que les ocurre. El objetivo es identificar la incidencia de conspiración de silencio familiar y su repercusión en los niveles de ansiedad y depresión del paciente diagnosticado de glioblastoma multiforme (GBM). Método: Los niveles de ansiedad y depresión fueron recogidos en cinco momentos del proceso de enfermedad: ingreso, después de la comunicación del diagnóstico, en el alta hospitalaria, un mes después del alta y seis meses después del alta. Las neces…

medicine.medical_specialtyIncidence (epidemiology)depresiónansiedadDiseaseAnxietyconspiración de silenciomedicine.diseaseSilenceconspiracy of silenceClinical PsychologyOncologydepressionglioblastoma multiforme.medicineAnxietyClinical significancemedicine.symptomPsychiatryPsychologyDepression (differential diagnoses)PsychopathologyGlioblastomaPsicooncología
researchProduct